|
|
Quarterly Results |
|
Fredun Pharmaceuticals Ltd | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Daulat N Medhora | Home : Indian Private | Book Value: 237.7852474 | BSE Code : 539730 | Market Cap: 396.16 | NSE Code : | P / E : 27.41 | |
| |
|
|
|
|
|
(Rs in Cr.) |
|
Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | Net Sales | 86.65 | 81.48 | 61.23 | 79.73 | Other Income | 0.00 | 0.00 | 0.00 | 0.00 | Total Income | 87.01 | 81.99 | 62.05 | 79.80 | Total Expenditure | 76.49 | 72.38 | 54.44 | 67.54 | Operating Profit | 10.52 | 9.61 | 7.61 | 12.26 | Interest | 3.77 | 2.90 | 2.61 | 3.55 | Gross Profit | 6.75 | 6.71 | 5.00 | 8.71 | Depreciation | 0.99 | 0.94 | 0.92 | 0.70 | Tax | 1.54 | 1.83 | 1.68 | 4.12 | Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | Reported Profit After Tax | 4.22 | 3.94 | 2.40 | 3.89 |
|
|
|
|
|